Sign In
24 Apr 2019 12:23
24 April 2019
Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).
Cathay International Holdings Limited
("Cathay", the "Company" or the "Group")
Update re. Starry Share Disposal
Hong Kong, 24 April 2019 - Cathay International Holdings Ltd. (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China, today notes Lansen Pharmaceutical Holdings Ltd ("Lansen") (HKEX: 503), the Company's 50.68% owned subsidiary, has released on 23 April 2019 a circular and notice of extraordinary general meeting in relation to its proposed sale of shares in Zheijang Starry Pharmaceutical Co., Ltd. (the "Circular" and "Notice of EGM" respectively) in accordance with the requirements of its Hong Kong listing.
The full text of the Lansen Circular can be found at http://www3.hkexnews.hk/listedco/listconews/SEHK/2019/0423/LTN20190423097.pdf and is also be made available at the Announcements & Notices section of Lansen's homepage at http://holding.lansen.com.cn/en/newslist.aspx?NodeCode=10002000700050005.
The full text of the Lansen Notice of EGM can be found at http://www3.hkexnews.hk/listedco/listconews/SEHK/2019/0423/LTN20190423101.pdf and is also be made available at the Announcements & Notices section of Lansen's homepage at http://holding.lansen.com.cn/en/newslist.aspx?NodeCode=10002000700050005.
For further enquiries, please contact:
Cathay International Holdings Limited Eric Siu (Finance Director) Patrick Sung (Director and Controller)
|
Tel: +852 2828 9289 |
Consilium Strategic Communications Mary-Jane Elliott / Matthew Neal / Lindsey Neville
|
Tel: +44 (0) 203 709 5702
|
Follow the stocks
